Matthew Dankner

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Journal: Cancer treatment reviews

Published: May 01, 2026

Distinct immune landscapes characterize highly versus minimally invasive brain metastases.

Distinct immune landscapes characterize highly versus minimally invasive brain metastases.

Journal: JCI insight

Published: August 25, 2025

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2025

Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-Analysis.

Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-Analysis.

Journal: Current oncology (Toronto, Ont.)

Published: July 26, 2025

Cold-inducible RNA-binding protein is associated with subtype-specific breast cancer patient outcomes.

Cold-inducible RNA-binding protein is associated with subtype-specific breast cancer patient outcomes.

Journal: Breast cancer research : BCR

Published: March 23, 2025

Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic Cancers.

Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic Cancers.

Journal: JCO precision oncology

Published: January 27, 2025

Machine learning prediction of brain metastasis invasion pattern on brain magnetic resonance imaging scans.

Machine learning prediction of brain metastasis invasion pattern on brain magnetic resonance imaging scans.

Journal: Neuro-oncology advances

Published: December 16, 2024

The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre.

The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre.

Journal: Current oncology (Toronto, Ont.)

Published: October 15, 2024

Cerebral spinal fluid analyses and therapeutic implications for leptomeningeal metastatic disease.

Cerebral spinal fluid analyses and therapeutic implications for leptomeningeal metastatic disease.

Journal: Journal of neuro-oncology

Published: September 22, 2024

A potential central nervous system niche for trastuzumab deruxtecan in patients with HER2-expressing non-small cell lung cancer.

A potential central nervous system niche for trastuzumab deruxtecan in patients with HER2-expressing non-small cell lung cancer.

Journal: Translational lung cancer research

Published: September 20, 2024

Antibody-Drug Conjugates for the Treatment of Non-Small Cell Lung Cancer with Central Nervous System Metastases.

Antibody-Drug Conjugates for the Treatment of Non-Small Cell Lung Cancer with Central Nervous System Metastases.

Journal: Current oncology (Toronto, Ont.)

Published: September 19, 2024

CNS activity of trastuzumab deruxtecan in HER2-expressing non-small-cell lung cancer.

CNS activity of trastuzumab deruxtecan in HER2-expressing non-small-cell lung cancer.

Journal: The Lancet. Oncology

Published: April 16, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026